At Keryx, the patient comes first. Our goal is to bring innovative therapies to market that provide unique and meaningful advantages to patients with renal disease and their healthcare providers…because

when patients come first, everybody succeeds.

The National Kidney Foundation estimates that nearly 450,000 Americans live with end-stage renal failure and require dialysis.

You are leaving

You are leaving, a website of Keryx Biopharmaceuticals, Inc. Keryx does not review or control the content of non-Keryx websites, and this hyperlink does not constitute an endorsement by Keryx of the site’s content. Keryx’s privacy procedures do not apply to the owners of a non-Keryx website.